2023-08-08 14:25:54 ET
- Agile Therapeutics ( NASDAQ: AGRX ) is scheduled to announce Q2 earnings results on Wednesday, August 9th, before market open.
- The consensus EPS Estimate is -$4.95 (-82.7% Y/Y) and the consensus Revenue Estimate is $4.63M (+120.5% Y/Y).
- Over the last 1 year, AGRX has beaten EPS estimates 100% of the time and has beaten revenue estimates 25% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 1 upward revision and 0 downward.
For further details see:
Agile Therapeutics Q2 2023 Earnings Preview